Adrenocortical Carcinoma

Information, Symptoms, Treatments and Resources

Blank
Previous | Next
Definition

Adrenocortical carcinoma is a cancer of the adrenal glands.

Alternative Names

Tumor - adrenal

Causes, incidence, and risk factors

Adrenocortical carcinoma is most common in children younger than 5 and adults in their 30s and 40s.

Adrenocortical carcinoma may be linked to a cancer syndrome that is passed down through families (inherited). Both men and women can develop this tumor. In women the tumor often releases hormones. Adrenocortical carcinoma can produce the hormones cortisol or aldosterone.

The cause is unknown. About 2 people per million develop this type of tumor.

Symptoms

Symptoms that suggest increased cortisol production:

Symptoms that suggest increased aldosterone production are the same as symptoms of low potassium (weakness, muscle cramps, increased thirst, and urination).

Treatment

Primary treatment is surgery to remove the tumor. Adrenocortical carcinoma may not improve with chemotherapy. Medications may be given to reduce production of cortisol, which causes many of the symptoms.

Expectations (prognosis)

The outcome depends on how early the diagnosis is made and whether the tumor has spread (metastasized). Metastatic tumors are often fatal within a few years.

Complications

A complication is metastasis (often to the liver, bone, and lung).

Calling your health care provider

Call your health care provider if you or your child has symptoms of adrenocortical carcinoma, Cushing syndrome, or failure to grow.

References

Abeloff M, Armitage J, Niederhuber J, Kastan M, McKenna WG. Clinical Oncology. 3rd ed. Philadelphia, Pa: Churchill Livingstone, 2004.

Assié G, Antoni G, Tissier F, et al. Prognostic parameters of metastatic adrenocortical carcinoma. J Clin Endocrinol Metab. January 2007;92:148-154.

Allolio B, Fassnacht M. Adrenocortical carcinoma: clinical update. J Clin Endocrinol Metab. June 1, 2006;91:2027-2037.

Previous | Next
Review date: March 13, 2007
Reviewed by: Mark Levin, M.D., Hematologist and Oncologist, Newark, NJ. Review provided by VeriMed Healthcare Network.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. � 1997- 2008 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

MedHelp Health Answers
Submit